RLMD
RELMADA THERAPEU (RLMD)
NASDAQ
$3.67+$0.005 (+0.14%)
Price as of Oct 02, 2026 6:09 PM EDT
  • $390.4M
    Market Cap
  • 37.59%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 38
Valuation
RLMD
vs History
vs S&P 500
Profitability
-1
Growth
0
Low Earnings Volatility
1

Momentum Score

Score: 30
Valuation
RLMD
vs History
vs S&P 500
3-Month Momentum
-35.55%
12-Month Momentum
106.48%
3-Month Risk Adjusted Momentum
-149.20%
12-Month Risk Adjusted Momentum
106.12%

True Yield

N/A
Valuation
RLMD
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
1.35%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 89
Valuation
RLMD
vs History
vs S&P 500
Ohlson's O-Score
-2